Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 785,000 | 1,005,000 | 1,093,000 | 1,058,000 | 1,014,000 |
| Cost of Goods | 140,000 | 128,000 | 104,000 | 107,000 | 97,000 |
| Gross Profit | 645,000 | 877,000 | 989,000 | 951,000 | 917,000 |
| Operating Expenses | 467,000 | 585,000 | 796,000 | 802,000 | 571,000 |
| Operating Income | 178,000 | 292,000 | 193,000 | 149,000 | 346,000 |
| Interest Expense | 22,000 | 31,000 | 63,000 | 51,000 | 61,000 |
| Other Income | 24,000 | 17,000 | 7,000 | 0 | 0 |
| Pre-tax Income | 180,000 | 278,000 | 137,000 | 98,000 | 285,000 |
| Income Tax | 46,000 | 3,000 | 79,000 | 63,000 | 57,000 |
| Net Income Continuous | 134,000 | 275,000 | 58,000 | 35,000 | 228,000 |
| Net Income | $134,000 | $275,000 | $58,000 | $35,000 | $228,000 |
| EPS Basic Total Ops | 0.90 | 1.90 | 0.40 | 0.25 | 1.60 |
| EPS Basic Continuous Ops | 0.92 | 1.89 | 0.40 | 0.24 | 1.59 |
| EPS Diluted Total Ops | 0.90 | 1.85 | 0.40 | 0.25 | 1.55 |
| EPS Diluted Continuous Ops | 0.89 | 1.83 | 0.40 | 0.24 | 1.56 |
| EPS Diluted Before Non-Recurring Items | 1.15 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $206,000 | $332,000 | $206,000 | $163,000 | $378,000 |